During the past decade, Kibong'oto Infectious Diseases Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kibong'oto Infectious Diseases Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kibong'oto Infectious Diseases Hospital" are "HIV I Infection" (1 trials), "Sepsis" (1 trials), "Tuberculosis" (1 trials) and "Tuberculosis, Multidrug-Resistant" (1 trials). Many other conditions were trialed in "Kibong'oto Infectious Diseases Hospital" in a lesser frequency.

Most popular intervention types in "Kibong'oto Infectious Diseases Hospital" are "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Centralized Therapeutic Drug Monitoring" (1 trials), "Immediate anti-TB therapy" (1 trials) and "Sepsis-specific dose anti-TB therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kibong'oto Infectious Diseases Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kibong'oto Infectious Diseases Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kibong'oto Infectious Diseases Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kibong'oto Infectious Diseases Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".